Fredun Pharmaceuticals has informedthat the meeting of the Board of Directors of the Company is scheduled on16/12/2023 ,inter alia, to consider and approve for fund raising upto Rs. 120crores by way of further public offer, right issue, ADR/GDR/FCCB, QIP, Debtissue, preferential issue or any other method.
The above information is a part of company’s filingssubmitted to BSE.